Article
Metabolic imaging across scales reveals distinct prostate cancer phenotypes.
Nature communications - 16 Jul 2024
Sushentsev Nikita, Hamm Gregory, Flint Lucy, Birtles Daniel, Zakirov Aleksandr, Richings Jack, Ling Stephanie, Tan Jennifer Y, McLean Mary A, Ayyappan Vinay, Horvat Menih Ines, Brodie Cara, Miller Jodi L, Mills Ian G, Gnanapragasam Vincent J, Warren Anne Y, Barry Simon T, Goodwin Richard J A, Barrett Tristan, Gallagher Ferdia A
Abstract excerpt
Hyperpolarised magnetic resonance imaging (HP-13C-MRI) has shown promise as a clinical tool for detecting and characterising prostate cancer. Here we use a range of spatially resolved histological techniques to identify the biological mechanisms underpinning differential [1-13C]lactate labelling between benign and malignant prostate, as well as in tumours containing cribriform and non-cribriform Gleason pattern 4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
